Suren G. Dutia - Aug 12, 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Stock symbol
CTOR
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4
Date filed
8/14/2024, 06:29 PM
Previous filing
Oct 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +150K $0.00 150K Aug 12, 2024 Common Stock 150K $2.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

Remarks:

Exhibit 24.1: Power of Attorney